AUG 12, 2026 · JOURNAL ARTICLE
Proteogenomic characterization of pulmonary large-cell neuroendocrine carcinoma identifies molecular features and therapeutic strategy
Science Advances
Proteogenomic characterization study identifying molecular subtypes and proposing IL-33 as a therapeutic target, with preclinical validation in animal models but no clinical efficacy data in patients.
Reported
Sample size107
Pure LCNEC cases81
Combined LCNEC cases26